Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Thrombin inhibitors revealed by Merck & Co.

June 10, 1997

Merck & Co. fibrinogen antagonist characterized in animals

June 9, 1997

Fibrinogen antagonists from Merck & Co.

June 6, 1997

First launch for lepirudin

June 5, 1997

Orally active antiplatelet agents described by Taisho

June 3, 1997

Astra shifts focus to newer thrombin inhibitor

June 2, 1997

Wyeth-Ayerst's Normiflo approved for prevention of deep vein thrombosis

June 2, 1997

Nissan Chem. reveals antiplatelet agents

May 29, 1997

Neutralase effective for heparin reversal in CAB

May 27, 1997

Texas Biotechnology reports phase III results with Novastan in HIT and HITTS

May 23, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...